Ian H Treasaden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ian H Treasaden has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Basant K. Puri
Cambridge Advanced Research, Cambridge CB21, UK
4 shared publications - Brian M. Ross
Division of Medical Sciences, Northern Ontario School of Medicine, Lakehead University, Room MS 3002, 955 Oliver Road, Thunder Bay, Ontario, Canada P7B 5E1, and Department of Chemistry, Lakehead University, and Public Health Program, Lakehead University, Thunder Bay, Ont., Canada P7B 5E1
2 shared publications - Marcelo G Bustos
Three Bridges Medium Secure Unit, West London Mental Health NHS Trust, Uxbridge Road, Southall, Middlesex UB1 3EU, UK
2 shared publications - Serena J Counsell
MRI Unit, MRC Clinical Sciences Centre, Imaging Sciences Department, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK
2 shared publications - Gavin Hamilton
Department of Radiology, University of California San Diego, San Diego, Calif
1 shared publication - Graeme M. Bydder
Department of Radiology, University of California, San Diego, San Diego, California, USA
1 shared publication
Latest Publications
- Open Access
- 17 April 2008
- Published by Springer Nature in BMC Psychiatry
- Vol. 8 (S1) , S7
Cerebral spectroscopic and oxidative stress studies in patients with schizophrenia who have dangerously violently offended
The aim of this study was to bring together all the results of in vivo studies of ethane excretion and cerebral spectroscopy in patients with schizophrenia who have dangerously seriously violently offended in order to determine the extent to which they shed light on the degree to which the membrane phospholipid hypothesis and the actions of free radicals and other reactive species are associated with cerebral pathophysiological mechanisms in this group of patients.
- 17 April 2008
- Published by Springer Nature in BMC Psychiatry
- Vol. 8 (S1) , S7
Open AccessCerebral spectroscopic and oxidative stress studies in patients with schizophrenia who have dangerously violently offended
The aim of this study was to bring together all the results of in vivo studies of ethane excretion and cerebral spectroscopy in patients with schizophrenia who have dangerously seriously violently offended in order to determine the extent to which they shed light on the degree to which the membrane phospholipid hypothesis and the actions of free radicals and other reactive species are associated with cerebral pathophysiological mechanisms in this group of patients.
- Open Access
- 17 April 2008
- Published by Springer Nature in BMC Psychiatry
- Vol. 8 (S1) , S6
Regional grey matter volumetric changes in forensic schizophrenia patients: an MRI study comparing the brain structure of patients who have seriously and violently offended with that of patients who have not
The aim was to carry out the first voxel-based morphometry study of grey matter changes in the whole brain in schizophrenia associated with a history of seriously and violently offending.
- 17 April 2008
- Published by Springer Nature in BMC Psychiatry
- Vol. 8 (S1) , S6
Open AccessRegional grey matter volumetric changes in forensic schizophrenia patients: an MRI study comparing the brain structure of patients who have seriously and violently offended with that of patients who have not
The aim was to carry out the first voxel-based morphometry study of grey matter changes in the whole brain in schizophrenia associated with a history of seriously and violently offending.
- Open Access
- 17 April 2008
- Published by Springer Nature in BMC Psychiatry
- Vol. 8 (S1) , S4
A comparison of oxidative stress in smokers and non-smokers: an in vivo human quantitative study of n-3 lipid peroxidation
Background: Cigarette smoking is believed to cause oxidative stress by several mechanisms, including direct damage by radical species and the inflammatory response induced by smoking, and would therefore be expected to cause increased lipid peroxidation. The aim was to carry out the first study of the relationship of smoking in humans to the level of n-3 lipid peroxidation indexed by the level of ethane in exhaled breath. Methods: Samples of alveolar air were obtained from 11 smokers and 18 non-smokers. The air samples were analyzed for ethane using mass spectrometry. Results: The two groups of subjects were matched with respect to age and gender. The mean cumulative smoking status of the smokers was 11.8 (standard error 2.5) pack-years. The mean level of ethane in the alveolar breath of the group of smokers (2.53 (0.55) ppb) was not significantly different from that of the group of non-smokers (2.59 (0.29) ppb; p = 0.92). With all 29 subjects included, the Spearman rank correlation coefficient between ethane levels and cumulative smoking status was -0.11 (p = 0.58), while an analysis including only the smokers yielded a corresponding correlation coefficient of 0.11 (p = 0.75). Conclusion: Our results show no evidence that cigarette smoking is related to increased n-3 lipid peroxidation as measured by expired ethane.
- 17 April 2008
- Published by Springer Nature in BMC Psychiatry
- Vol. 8 (S1) , S4
Open AccessA comparison of oxidative stress in smokers and non-smokers: an in vivo human quantitative study of n-3 lipid peroxidation
Background: Cigarette smoking is believed to cause oxidative stress by several mechanisms, including direct damage by radical species and the inflammatory response induced by smoking, and would therefore be expected to cause increased lipid peroxidation. The aim was to carry out the first study of the relationship of smoking in humans to the level of n-3 lipid peroxidation indexed by the level of ethane in exhaled breath. Methods: Samples of alveolar air were obtained from 11 smokers and 18 non-smokers. The air samples were analyzed for ethane using mass spectrometry. Results: The two groups of subjects were matched with respect to age and gender. The mean cumulative smoking status of the smokers was 11.8 (standard error 2.5) pack-years. The mean level of ethane in the alveolar breath of the group of smokers (2.53 (0.55) ppb) was not significantly different from that of the group of non-smokers (2.59 (0.29) ppb; p = 0.92). With all 29 subjects included, the Spearman rank correlation coefficient between ethane levels and cumulative smoking status was -0.11 (p = 0.58), while an analysis including only the smokers yielded a corresponding correlation coefficient of 0.11 (p = 0.75). Conclusion: Our results show no evidence that cigarette smoking is related to increased n-3 lipid peroxidation as measured by expired ethane.
- Open Access
- 17 April 2008
- Published by Springer Nature in BMC Psychiatry
- Vol. 8 (S1) , S2
Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans
This study tested the hypothesis that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans. Ethane is released specifically following peroxidation of n-3 polyunsaturated fatty acids. We reasoned that the cerebral source of ethane would be the docosahexaenoic acid component of membrane phospholipids. Breakdown of the latter also releases phosphorylated polar head groups, giving rise to glycerophosphorylcholine and glycerophosphorylethanolamine, which can be measured from the 31-phosphorus neurospectroscopy phosphodiester peak. Schizophrenia patients were chosen because of evidence of increased free radical-mediated damage and cerebral lipid peroxidation in this disorder.
- 17 April 2008
- Published by Springer Nature in BMC Psychiatry
- Vol. 8 (S1) , S2
Open AccessEvidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans
This study tested the hypothesis that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans. Ethane is released specifically following peroxidation of n-3 polyunsaturated fatty acids. We reasoned that the cerebral source of ethane would be the docosahexaenoic acid component of membrane phospholipids. Breakdown of the latter also releases phosphorylated polar head groups, giving rise to glycerophosphorylcholine and glycerophosphorylethanolamine, which can be measured from the 31-phosphorus neurospectroscopy phosphodiester peak. Schizophrenia patients were chosen because of evidence of increased free radical-mediated damage and cerebral lipid peroxidation in this disorder.